Tenet 保健THC
紐約證券 · USD
261.19
-3.32
(-1.26%)
盤中 09/16 02:07 (UTC+8)
09/16 02:07 (UTC+8)
Tenet 保健THC
261.19
-3.32
(-1.26%)
財務數據
損益表
- 53.68
- 51.03
- 51.22
- 50.63
- 52.23
- 52.71
- 52.89
- 55.27
- 57.81
- 60.41
- -0.20
- -4.94
- 0.37
- -1.15
- 2.98
- 0.92
- 0.34
- 4.50
- 4.60
- 4.50
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 6,041,000 | 5,781,000 | 5,527,000 | 5,289,000 | 5,271,000 | 5,223,000 | 5,063,000 | 5,122,000 | 5,103,000 | 5,368,000 |
營業成本 | 984,000 | 961,000 | 1,010,000 | 931,000 | 932,000 | 907,000 | 930,000 | 881,000 | 908,000 | 928,000 |
營業毛利 | 5,057,000 | 4,820,000 | 4,517,000 | 4,358,000 | 4,339,000 | 4,316,000 | 4,133,000 | 4,241,000 | 4,195,000 | 4,440,000 |
營業費用 | 3,654,000 | 3,576,000 | 3,742,000 | 3,553,000 | 3,539,000 | - | 3,410,000 | 3,566,000 | 3,558,000 | 3,714,000 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | 3,405,000 | 3,296,000 | 3,417,000 | 3,323,000 | 3,279,000 | 3,209,000 | 3,173,000 | 3,329,000 | 3,316,000 | 3,475,000 |
非經常性項目費用 | 34,000 | 51,000 | 94,000 | 12,000 | 52,000 | 36,000 | 44,000 | 28,000 | 34,000 | 31,000 |
其他營業費用 | 215,000 | 229,000 | 231,000 | 218,000 | 208,000 | 206,000 | 193,000 | 209,000 | 208,000 | 208,000 |
營業利益 | 1,501,000 | 1,296,000 | 853,000 | 889,000 | 823,000 | 943,000 | 821,000 | 1,089,000 | 761,000 | 3,285,000 |
其他收入及費用 | 76,000 | 42,000 | 28,000 | 49,000 | -13,000 | 48,000 | 57,000 | 387,000 | 92,000 | 2,517,000 |
利息費用 | 204,000 | 205,000 | 205,000 | 206,000 | 206,000 | 204,000 | 203,000 | 202,000 | 203,000 | 218,000 |
稅前純益 | 1,340,000 | 1,132,000 | 681,000 | 712,000 | 642,000 | 765,000 | 655,000 | 922,000 | 587,000 | 3,084,000 |
所得稅 | 295,000 | 226,000 | 37,000 | 133,000 | 120,000 | 143,000 | 83,000 | 241,000 | 110,000 | 750,000 |
稅後純益 | 826,000 | 702,000 | 371,000 | 342,000 | 288,000 | 406,000 | 318,000 | 472,000 | 259,000 | 2,151,000 |
基本每股稅後盈餘(元) | 9.89 | 8.09 | 4.25 | 3.89 | 3.16 | 4.31 | 3.34 | 4.93 | 2.66 | 21.60 |
稀釋每股稅後盈餘(元) | 9.80 | 8.01 | 4.21 | 3.85 | 3.14 | 4.27 | 3.43 | 5.05 | 2.84 | 21.38 |
基本平均股數(千股) | 83524.00 | 86801.00 | 87271.00 | 87951.00 | 91135.00 | 94242.00 | 95102.00 | 95665.00 | 97267.00 | 99581.00 |
稀釋平均股數(千股) | 83964.00 | 87596.00 | 87917.00 | 88610.00 | 91791.00 | 95019.00 | 95882.00 | 96652.00 | 98444.00 | 100598.00 |
還原基本每股稅後盈餘(元) | 9.89 | 8.09 | 4.25 | 3.89 | 3.16 | 4.31 | 3.34 | 4.93 | 2.66 | 21.60 |
還原稀釋每股稅後盈餘(元) | 9.80 | 8.01 | 4.21 | 3.85 | 3.14 | 4.27 | 3.43 | 5.05 | 2.84 | 21.38 |
還原基本平均股數(千股) | 83,524 | 86,801 | 87,271 | 87,951 | 91,135 | 94,242 | 95,102 | 95,665 | 97,267 | 99,581 |
還原稀釋平均股數(千股) | 83,964 | 87,596 | 87,917 | 88,610 | 91,791 | 95,019 | 95,882 | 96,652 | 98,444 | 100,598 |
EBITDA(千元) | 1,546,000 | 1,367,000 | 849,000 | 905,000 | 828,000 | 965,000 | 802,000 | 1,131,000 | 786,000 | 3,335,000 |